Trial · NCT01426438
Adverse events46
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 46
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal pain | Gastrointestinal disorders | Arm A: Extended-release Niacin With Aspirin | 3 | 50 | |
| other | Abdominal pain | Gastrointestinal disorders | Arm B: Fenofibrate | 1 | 49 | |
| other | Diarrhoea | Gastrointestinal disorders | Arm A: Extended-release Niacin With Aspirin | 3 | 50 | |
| other | Diarrhoea | Gastrointestinal disorders | Arm B: Fenofibrate | 0 | 49 | |
| other | Nausea | Gastrointestinal disorders | Arm A: Extended-release Niacin With Aspirin | 7 | 50 | |
| other | Nausea | Gastrointestinal disorders | Arm B: Fenofibrate | 2 | 49 | |
| other | Vomiting | Gastrointestinal disorders | Arm A: Extended-release Niacin With Aspirin | 4 | 50 | |
| other | Vomiting | Gastrointestinal disorders | Arm B: Fenofibrate | 1 | 49 | |
| other | Fatigue | General disorders | Arm A: Extended-release Niacin With Aspirin | 3 | 50 | |
| other | Fatigue | General disorders | Arm B: Fenofibrate | 0 | 49 | |
| other | Alanine aminotransferase increased | Investigations | Arm A: Extended-release Niacin With Aspirin | 8 | 50 | |
| other | Alanine aminotransferase increased | Investigations | Arm B: Fenofibrate | 7 | 49 | |
| other | Aspartate aminotransferase increased | Investigations | Arm A: Extended-release Niacin With Aspirin | 10 | 50 | |
| other | Aspartate aminotransferase increased | Investigations | Arm B: Fenofibrate | 4 | 49 | |
| other | Blood alkaline phosphatase increased | Investigations | Arm A: Extended-release Niacin With Aspirin | 7 | 50 | |
| other | Blood alkaline phosphatase increased | Investigations | Arm B: Fenofibrate | 0 | 49 | |
| other | Blood bilirubin increased | Investigations | Arm A: Extended-release Niacin With Aspirin | 17 | 50 | |
| other | Blood bilirubin increased | Investigations | Arm B: Fenofibrate | 8 | 49 | |
| other | Blood cholesterol increased | Investigations | Arm A: Extended-release Niacin With Aspirin | 11 | 50 | |
| other | Blood cholesterol increased | Investigations | Arm B: Fenofibrate | 12 | 49 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01426438/events